The pooled analysis numerically favored TARE over TACE (HR: 0.54; 95% CI: 0.29–1.01; Figure 2 C), although the difference did not reach statistical significance.
← all excerpts
Transarterial Chemoembolization Versus Transarterial Radioembolization in Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis of Real-World and Clinical Trial Evidence.
1
—
—